Navigation Links
AHF's Innovative 'Stay Negative' HIV Prevention Campaign Successfully Breaks Through to Target Audience
Date:10/4/2007

xual, 44% were white, 25% were Latino and 23% were African-American.

Sophia Rumanes, Chief of the Prevention Services Division for the Los Angeles Department of Public Health's Office of AIDS Programs and Policy states, "We commend AHF's social marketing campaign and parallel evaluation strategy. In a County where 1 in 4 of its residents living with HIV is unaware of their infection, efforts to promote health and encourage HIV testing is crucial."

AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS healthcare, research, prevention and education provider. AHF currently provides medical care and/or services to more than 61,000 individuals in 15 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at http://www.aidshealth.org.

If you have received this news release in error and do not wish to receive future advisories, or if they should be directed to someone else in your organization, please call (323) 860-5262. Alternatively, you may fax your updated information or your request for removal from our list to (323) 962- 8513 or e-mail jennifer.ramirez@aidshealth.org.


'/>"/>
SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Innovative footwear may prevent fall in elderly
3. Innovative yeast genome may handle Cancer Clues
4. Innovative solution to help reduce the waiting times for kidney transplants
5. Personalized Medicine and Innovative Pharmaceuticals
6. Creation of Cytomegalovirus Vaccine by an Innovative Method
7. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
8. Innovative treatment for Dementia
9. Innovative treatment for Skin Cancer
10. Innovative Movies Show Real-Time Immune-Cell Activity within Tumors
11. Research In A New Direction To Develop Innovative Psychotropic Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 1Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 2Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 3Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 1Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 2Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 3Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 4Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 5